Literature DB >> 12191961

The pathogenesis of oral lichen planus.

P B Sugerman1, N W Savage, L J Walsh, Z Z Zhao, X J Zhou, A Khan, G J Seymour, M Bigby.   

Abstract

Both antigen-specific and non-specific mechanisms may be involved in the pathogenesis of oral lichen planus (OLP). Antigen-specific mechanisms in OLP include antigen presentation by basal keratinocytes and antigen-specific keratinocyte killing by CD8(+) cytotoxic T-cells. Non-specific mechanisms include mast cell degranulation and matrix metalloproteinase (MMP) activation in OLP lesions. These mechanisms may combine to cause T-cell accumulation in the superficial lamina propria, basement membrane disruption, intra-epithelial T-cell migration, and keratinocyte apoptosis in OLP. OLP chronicity may be due, in part, to deficient antigen-specific TGF-beta1-mediated immunosuppression. The normal oral mucosa may be an immune privileged site (similar to the eye, testis, and placenta), and breakdown of immune privilege could result in OLP and possibly other autoimmune oral mucosal diseases. Recent findings in mucocutaneous graft-versus-host disease, a clinical and histological correlate of lichen planus, suggest the involvement of TNF-alpha, CD40, Fas, MMPs, and mast cell degranulation in disease pathogenesis. Potential roles for oral Langerhans cells and the regional lymphatics in OLP lesion formation and chronicity are discussed. Carcinogenesis in OLP may be regulated by the integrated signal from various tumor inhibitors (TGF-beta 1, TNF-alpha, IFN-gamma, IL-12) and promoters (MIF, MMP-9). We present our recent data implicating antigen-specific and non-specific mechanisms in the pathogenesis of OLP and propose a unifying hypothesis suggesting that both may be involved in lesion development. The initial event in OLP lesion formation and the factors that determine OLP susceptibility are unknown.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12191961     DOI: 10.1177/154411130201300405

Source DB:  PubMed          Journal:  Crit Rev Oral Biol Med        ISSN: 1045-4411


  150 in total

1.  Relationships of personality factors to perceived stress, depression, and oral lichen planus severity.

Authors:  Kurosh Mohamadi Hasel; Mohamad Ali Besharat; Amir Abdolhoseini; Somaye Alaei Nasab; Seyran Niknam
Journal:  Int J Behav Med       Date:  2013-06

2.  Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease.

Authors:  Hemalatha Rangarajan; Maryam Yassai; Hariharan Subramanian; Richard Komorowski; Megan Whitaker; Jack Gorski; William R Drobyski
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

3.  Evaluation of the Efficacy of Curcumin in the Treatment of Oral Lichen Planus: A Randomized Controlled Trial.

Authors:  Maryam Amirchaghmaghi; Atessa Pakfetrat; Zahra Delavarian; Hanieh Ghalavani; Ala Ghazi
Journal:  J Clin Diagn Res       Date:  2016-05-01

4.  Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren's syndrome: association with mononuclear cell infiltration.

Authors:  C Molina; C Alliende; S Aguilera; Y-J Kwon; L Leyton; B Martínez; C Leyton; P Pérez; M-J González
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

5.  Isolated lichen planus of the conjunctiva.

Authors:  M Pakravan; T R Klesert; E K Akpek
Journal:  Br J Ophthalmol       Date:  2006-10       Impact factor: 4.638

Review 6.  Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.

Authors:  Chiaki Okuse; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

7.  Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells.

Authors:  S L Zunt; L V Burton; L I Goldblatt; E E Dobbins; M Srinivasan
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

8.  Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus.

Authors:  F Kalogerakou; E Albanidou-Farmaki; A K Markopoulos; D Z Antoniades
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

9.  Gene expression based evidence of innate immune response activation in the epithelium with oral lichen planus.

Authors:  Guy R Adami; Alexander C F Yeung; Grant Stucki; Antonia Kolokythas; Herve Y Sroussi; Robert J Cabay; Igor Kuzin; Joel L Schwartz
Journal:  Arch Oral Biol       Date:  2014-01-04       Impact factor: 2.633

10.  Topical pimecrolimus versus betamethasone for oral lichen planus: a randomized clinical trial.

Authors:  Ola M Ezzatt; Iman M Helmy
Journal:  Clin Oral Investig       Date:  2018-06-16       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.